Role of adiponectin in diabetes myocardial ischemia-reperfusion injury and ischemic postconditioning

Detalhes bibliográficos
Autor(a) principal: Cao,Chen
Data de Publicação: 2020
Outros Autores: Liu,Hui-min, Li,Wei, Wu,Yang, Leng,Yan, Xue,Rui, Chen,Rong, Tang,Ling-hua, Sun,Qian, Xia,Zhongyuan, Tang,Qi-zhu, Shen,Di-fei, Meng,Qing-tao
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Acta Cirúrgica Brasileira (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-86502020000100204
Resumo: Abstract Purpose Patients with diabetes are vulnerable to myocardial I/R (ischaemia/reperfusion) injury, but are not responsive to IPO (ischaemic post-conditioning). We hypothesized that decreased cardiac Adiponectin (APN) is responsible for the loss of diabetic heart sensitivity to IPO cardioprotecton. Methods Diabetic rats were subjected to I/R injury (30 min of LAD occlusion followed by 120 min of reperfusion). Myocardial infarct area was determined by TTC staining. Cardiac function was monitored by a microcatheter. ANP, 15-F2t-isoprostane, nitrotyrosine and MDA were measured by assay kits. Levels of p-Akt, total-Akt and GAPDH were determined by Western Blot. Results Diabetic rats subjected to myocardial IR exhibited severe myocardial infarction and oxidative stress injury, lower APN in the plasma and cardiac p-Akt expression ( P <0.05). IPO significantly attenuated myocardial injury and up-regulated plasma APN content and cardiac p-Akt expression in non-diabetic rats but not in diabetic rats. Linear correlation analysis showed that the expression of adiponectin was positively correlated with p-Akt and negatively correlated with myocardial infarction area ( P <0.01). Conclusion Protective effect of IPO was tightly correlated with the expression of adiponectin, exacerbation of I/R injury and ineffectiveness of IPO was partially due to the decline of adiponectin and inactivation of Akt in diabetes mellitus.
id SBDPC-1_a8585c764e20a86b6feb19ccf3a0b5d4
oai_identifier_str oai:scielo:S0102-86502020000100204
network_acronym_str SBDPC-1
network_name_str Acta Cirúrgica Brasileira (Online)
repository_id_str
spelling Role of adiponectin in diabetes myocardial ischemia-reperfusion injury and ischemic postconditioningAdiponectinDiabetesReperfusion InjuryIschemic PostconditioningAbstract Purpose Patients with diabetes are vulnerable to myocardial I/R (ischaemia/reperfusion) injury, but are not responsive to IPO (ischaemic post-conditioning). We hypothesized that decreased cardiac Adiponectin (APN) is responsible for the loss of diabetic heart sensitivity to IPO cardioprotecton. Methods Diabetic rats were subjected to I/R injury (30 min of LAD occlusion followed by 120 min of reperfusion). Myocardial infarct area was determined by TTC staining. Cardiac function was monitored by a microcatheter. ANP, 15-F2t-isoprostane, nitrotyrosine and MDA were measured by assay kits. Levels of p-Akt, total-Akt and GAPDH were determined by Western Blot. Results Diabetic rats subjected to myocardial IR exhibited severe myocardial infarction and oxidative stress injury, lower APN in the plasma and cardiac p-Akt expression ( P <0.05). IPO significantly attenuated myocardial injury and up-regulated plasma APN content and cardiac p-Akt expression in non-diabetic rats but not in diabetic rats. Linear correlation analysis showed that the expression of adiponectin was positively correlated with p-Akt and negatively correlated with myocardial infarction area ( P <0.01). Conclusion Protective effect of IPO was tightly correlated with the expression of adiponectin, exacerbation of I/R injury and ineffectiveness of IPO was partially due to the decline of adiponectin and inactivation of Akt in diabetes mellitus.Sociedade Brasileira para o Desenvolvimento da Pesquisa em Cirurgia2020-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-86502020000100204Acta Cirúrgica Brasileira v.35 n.1 2020reponame:Acta Cirúrgica Brasileira (Online)instname:Sociedade Brasileira para o Desenvolvimento da Pesquisa em Cirurgia (SBDPC)instacron:SBDPC10.1590/s0102-865020200010000007info:eu-repo/semantics/openAccessCao,ChenLiu,Hui-minLi,WeiWu,YangLeng,YanXue,RuiChen,RongTang,Ling-huaSun,QianXia,ZhongyuanTang,Qi-zhuShen,Di-feiMeng,Qing-taoeng2020-03-18T00:00:00Zoai:scielo:S0102-86502020000100204Revistahttps://www.bvs-vet.org.br/vetindex/periodicos/acta-cirurgica-brasileira/https://old.scielo.br/oai/scielo-oai.php||sgolden@terra.com.br0102-86501678-2674opendoar:2020-03-18T00:00Acta Cirúrgica Brasileira (Online) - Sociedade Brasileira para o Desenvolvimento da Pesquisa em Cirurgia (SBDPC)false
dc.title.none.fl_str_mv Role of adiponectin in diabetes myocardial ischemia-reperfusion injury and ischemic postconditioning
title Role of adiponectin in diabetes myocardial ischemia-reperfusion injury and ischemic postconditioning
spellingShingle Role of adiponectin in diabetes myocardial ischemia-reperfusion injury and ischemic postconditioning
Cao,Chen
Adiponectin
Diabetes
Reperfusion Injury
Ischemic Postconditioning
title_short Role of adiponectin in diabetes myocardial ischemia-reperfusion injury and ischemic postconditioning
title_full Role of adiponectin in diabetes myocardial ischemia-reperfusion injury and ischemic postconditioning
title_fullStr Role of adiponectin in diabetes myocardial ischemia-reperfusion injury and ischemic postconditioning
title_full_unstemmed Role of adiponectin in diabetes myocardial ischemia-reperfusion injury and ischemic postconditioning
title_sort Role of adiponectin in diabetes myocardial ischemia-reperfusion injury and ischemic postconditioning
author Cao,Chen
author_facet Cao,Chen
Liu,Hui-min
Li,Wei
Wu,Yang
Leng,Yan
Xue,Rui
Chen,Rong
Tang,Ling-hua
Sun,Qian
Xia,Zhongyuan
Tang,Qi-zhu
Shen,Di-fei
Meng,Qing-tao
author_role author
author2 Liu,Hui-min
Li,Wei
Wu,Yang
Leng,Yan
Xue,Rui
Chen,Rong
Tang,Ling-hua
Sun,Qian
Xia,Zhongyuan
Tang,Qi-zhu
Shen,Di-fei
Meng,Qing-tao
author2_role author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Cao,Chen
Liu,Hui-min
Li,Wei
Wu,Yang
Leng,Yan
Xue,Rui
Chen,Rong
Tang,Ling-hua
Sun,Qian
Xia,Zhongyuan
Tang,Qi-zhu
Shen,Di-fei
Meng,Qing-tao
dc.subject.por.fl_str_mv Adiponectin
Diabetes
Reperfusion Injury
Ischemic Postconditioning
topic Adiponectin
Diabetes
Reperfusion Injury
Ischemic Postconditioning
description Abstract Purpose Patients with diabetes are vulnerable to myocardial I/R (ischaemia/reperfusion) injury, but are not responsive to IPO (ischaemic post-conditioning). We hypothesized that decreased cardiac Adiponectin (APN) is responsible for the loss of diabetic heart sensitivity to IPO cardioprotecton. Methods Diabetic rats were subjected to I/R injury (30 min of LAD occlusion followed by 120 min of reperfusion). Myocardial infarct area was determined by TTC staining. Cardiac function was monitored by a microcatheter. ANP, 15-F2t-isoprostane, nitrotyrosine and MDA were measured by assay kits. Levels of p-Akt, total-Akt and GAPDH were determined by Western Blot. Results Diabetic rats subjected to myocardial IR exhibited severe myocardial infarction and oxidative stress injury, lower APN in the plasma and cardiac p-Akt expression ( P <0.05). IPO significantly attenuated myocardial injury and up-regulated plasma APN content and cardiac p-Akt expression in non-diabetic rats but not in diabetic rats. Linear correlation analysis showed that the expression of adiponectin was positively correlated with p-Akt and negatively correlated with myocardial infarction area ( P <0.01). Conclusion Protective effect of IPO was tightly correlated with the expression of adiponectin, exacerbation of I/R injury and ineffectiveness of IPO was partially due to the decline of adiponectin and inactivation of Akt in diabetes mellitus.
publishDate 2020
dc.date.none.fl_str_mv 2020-01-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-86502020000100204
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-86502020000100204
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/s0102-865020200010000007
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Sociedade Brasileira para o Desenvolvimento da Pesquisa em Cirurgia
publisher.none.fl_str_mv Sociedade Brasileira para o Desenvolvimento da Pesquisa em Cirurgia
dc.source.none.fl_str_mv Acta Cirúrgica Brasileira v.35 n.1 2020
reponame:Acta Cirúrgica Brasileira (Online)
instname:Sociedade Brasileira para o Desenvolvimento da Pesquisa em Cirurgia (SBDPC)
instacron:SBDPC
instname_str Sociedade Brasileira para o Desenvolvimento da Pesquisa em Cirurgia (SBDPC)
instacron_str SBDPC
institution SBDPC
reponame_str Acta Cirúrgica Brasileira (Online)
collection Acta Cirúrgica Brasileira (Online)
repository.name.fl_str_mv Acta Cirúrgica Brasileira (Online) - Sociedade Brasileira para o Desenvolvimento da Pesquisa em Cirurgia (SBDPC)
repository.mail.fl_str_mv ||sgolden@terra.com.br
_version_ 1752126445491060736